Skip to content
  • Recurrent respiratory papillomatosis Africa
  • Recurrent respiratory papillomatosis Africa
rrpafricarrpafrica
  • Home
  • Pledge-a-thon
  • Practitioners
  • FAQ
  • Contact us

Category Archives: Adjuvant therapy options

Immunological response to quadrivalent HPV vaccine in treatment of recurrent respiratory papillomatosis
30 September 2022

Abstract Abstract Aim of this study was to explore influence of the quadrivalent HPV vaccine [...]

Intersurgical interval increased with use of quadrivalent human papillomavirus vaccine (Gardasil) in a pediatric patient with recurrent respiratory papillomatosis: A case report
30 September 2022

Abstract This is a case of a 4 year old female with recalcitrant recurrent respiratory [...]

Therapeutic use of the HPV vaccine in recurrent respiratory papillomatosis: A case report
30 September 2022

Abstract Recurrent Respiratory Papillomatosis (RRP) is a condition characterized by recurring squamous papillomas in the [...]

Therapeutic use of the human papillomavirus vaccine on recurrent respiratory papillomatosis: A systematic review and meta-analysis
30 September 2022

Background: Recurrent respiratory papillomatosis is a benign condition caused by human papillomavirus (HPV). Surgery is [...]

RRP Africa is a non-profit organisation committed to enhancing the quality of life and medical care for RRP patients and the ultimate eradication of RRP in Africa.
Copyright 2025 © RRP Africa. Website by Quickfox Publishing
  • Home
  • Pledge-a-thon
  • Practitioners
  • FAQ
  • Contact us
  • Login
Pledge your support!

If you opt in, we use this information to send you related content and RRP updates.

Login

Lost your password?